Midocron-2.5 Tablet
Midodrine 2.5 mg
| Composition | Midodrine 2.5 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 10 x 10 (Alu-Alu) |
| MRP | ₹ 4400 |
| Therapy | Cardiac + Diabetic — Selective alpha-1 adrenergic agonist (orthostatic hypotension) |
| Storage | Store below 25°C. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Midocron-2.5 Tablet
Midocron-2.5 Tablet contains Midodrine 2.5 mg, a prodrug of desglymidodrine — a selective alpha-1 adrenergic agonist. It is the FDA-approved oral agent for symptomatic orthostatic hypotension.
Indicated for symptomatic neurogenic orthostatic hypotension, autonomic failure (pure autonomic failure, multiple system atrophy, Parkinson’s disease autonomic dysfunction), and dialysis-induced hypotension.
Camrut Healthcare manufactures the Midocron range under WHO-GMP conditions for PCD pharma franchise across India.
Indications
- Symptomatic neurogenic orthostatic hypotension
- Autonomic failure (pure autonomic failure, MSA, PD autonomic dysfunction)
- Dialysis-induced hypotension
- Refractory vasovagal syncope (adjunct)
Mechanism of Action
Midodrine is a prodrug rapidly converted to its active metabolite desglymidodrine, a selective alpha-1 adrenergic agonist. Activation of vascular alpha-1 receptors produces arteriolar and venous vasoconstriction, raising peripheral resistance and central venous return — thus increasing BP.
Dosage & Administration
['Adults: 2.5–10 mg three times daily', 'Take during daytime only (last dose by late afternoon)', 'Never take within 4 hours of bedtime (supine hypertension risk)', 'Monitor supine and seated BP']
Side Effects
['Supine hypertension (very common — biggest concern)', 'Pilomotor reaction (goose bumps)', 'Scalp pruritus', 'Urinary urgency', 'Paraesthesias']
Contraindications & Precautions
['Severe organic heart disease', 'Acute renal disease', 'Urinary retention', 'Phaeochromocytoma', 'Thyrotoxicosis', 'Supine systolic BP > 180 mmHg', 'Lying-down dosing (use only when upright)']
Storage
Store below 25°C.
Midocron-2.5 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products